Tilray Investor Relations

Official IR account of @Tilray. A lifestyle company leading the intersection of cannabis, craft beverage, and hemp industries.

Must be 21+ to follow $TLRY

[Tilray Investor Relations @TilrayIR]

Stay informed.

Get company news, updates, and key developments delivered directly to your inbox.

👉 Sign up for @Tilray investor alerts: https://t.co/ClGFYumxif $TLRY

[Tilray Brands @tilray]

The Pacific Northwest is ready. ⚽🌲🍻

@10BarrelBrewing x Pub Beer are kicking off a summer of soccer with watch parties, exclusive merch, giveaways and more.

Pull up and catch the match. https://t.co/hWUtaiXGpy $TLRY

[Tilray Brands @tilray]

Big moments. Bigger upsets. 🍻⚽

This summer, every match just got more interesting.

When underdogs shock the world, you could score a beer rebate on your @ShockTop.

Grab your crew, and cheer for the unexpected.

Learn more https://t.co/NotQtdBRkg $TLRY

[Tilray Brands @tilray]

.@BrewDog is celebrating Scotland’s return to the international stage by bringing pint prices back to 1998.

From June 14–16, £2 pints are pouring across BrewDog’s Scottish bars — with select locations also tapping Tilray’s U.S. craft beer portfolio.

Learn more https://t.co/IN3B3tpdL5

[Tilray Brands @tilray]

Tilray Brands is bringing American craft beer to the U.K.

Through @BrewDog, 24 craft favourites from across the U.S., including @sweetwaterbrew, @montaukbrewco, @10BarrelBrewing, @ShockTop, @AlpineBeerCo, @GreenFlashBeer, @TerrapinBeerCo, and Blue Point, are now available in bars across the U.K. and online.

As the 4th largest craft brewer in the U.S., this launch marks a key step in expanding our beverage footprint across Europe.

Learn more https://t.co/u1mfkySDxT $TLRY

[Tilray Brands @tilray]

Tilray Medical Germany has launched ARX™, a new premium medical cannabis brand developed and cultivated in Germany.

Built on proven genetics, German cultivation expertise, and rigorous quality standards, ARX reflects more than two years of development at our Aphria RX facility in Neumünster.

ARX will make its official debut at @hanfmesse Berlin 2026 this week, where attendees can visit Tilray Medical at Hall 20, Stand B21 to learn more.

Tap the link for full details https://t.co/gbsWSzQhLL $TLRY

[Tilray Brands @tilray]

.@BrewDog is turning this summer’s global football tournament into a UK-wide celebration of beer, bars and big match moments. ⚽🍻

From retail to bars to digital, the “Underdog” campaign brings it all together — including a chance to win a year of beer.

Read more: https://t.co/a9XQUs5hZH $TLRY

[Tilray Brands @tilray]

Tilray Medical brings global medical cannabis expertise to @cannabiseuropa London 2026.

Learn more https://t.co/p6pRG4oDkl $TLRY

[Tilray Brands @tilray]

. @BrewDog is giving RTDs a nostalgic twist in the UK.

The new Wonderland Cocktails bring familiar flavours to the shelf with Pear Drop Margarita and Fizzy Toffee Apple Martini.

Learn more https://t.co/l58mluc7JZ $TLRY

[Tilray Brands @tilray]

Meet Magic Hour IPA.

Bright, tropical, and built for that stretch of the day when everything slows down a bit. A new year‑round IPA from Blue Point Brewing Company.

Learn more https://t.co/sXUz0Wgv05 $TLRY

[IgniteIt Cannabis @IgniteItNews]

🚨EXCLUSIVE: @tilray CEO @IrwinDSimon says Schedule III could be a turning point for U.S. medical cannabis.

Key themes:

🏥 Medical legitimacy
💰 Institutional capital access
🔬 Research expansion
🌎 Long-term U.S. market opportunity

🖊️@AJHerrington1
https://t.co/bSpglVrUpT

[Tilray Brands @tilray]

For years, Tilray focused on building a global medical cannabis business designed for regulated healthcare markets.

Now, as the U.S. moves toward a federally regulated medical cannabis framework, the market is beginning to recognize the value of scale, science, pharmaceutical-grade infrastructure, and global operational expertise.

This is why Tilray Medical is positioned for the future of medical cannabis.

Read more via MJBizDaily:
https://t.co/fCNjqrLjJb…

$TLRY

[Tilray Brands @tilray]

Widmer Brothers has unveiled Stay Sunny, a bold new chapter for the historic Oregon brewery.

The campaign introduces refreshed packaging, new beers, and a multichannel brand refresh rooted in Portland and extending across Oregon and the Pacific Northwest, bringing renewed energy to a brand with deep craft heritage.

Learn more https://t.co/9g2BR9isA5 $TLRY

[Tilray Brands @tilray]

.@BrewDog has announced a new partnership with Underbelly, becoming the official beer supplier of Underbelly at the Edinburgh Fringe.

The 12‑month agreement also includes seasonal festival support in London and a permanent live venue, bringing together craft beer, comedy, and live performance in one of the world’s most iconic cultural festivals.

Learn more https://t.co/joRs4Z9SVp $TLRY

[Tilray Brands @tilray]

.@10BarrelBrewing is expanding its ready‑to‑drink portfolio with the launch of Clean Slate and Salty Sips—introducing a functional non‑alcoholic cocktail and a low‑sugar vodka refresher crafted for the season ahead.

Both offerings are made with real fruit juice and a pinch of Oregon Coast sea salt, reflecting 10 Barrel’s continued focus on innovation, flavor, and meeting evolving consumer preferences across emerging beverage categories.

Learn more https://t.co/eLl0gpshdh $TLRY

[Tilray Brands @tilray]

.@sweetwaterbrew has teamed up with @RealSaltLife to launch Livin’ Salty, a new summer craft brew inspired by sun, sand, and time well spent outdoors.

The collaboration brings together two brands rooted in lifestyle and community, delivering a refreshing lager designed for the season ahead and moments that define summer.

Learn more https://t.co/dmjz8xqhtQ $TLRY

📷Photo Credit: Ryan Forbus

[Tilray Brands @tilray]

Rescheduling is here. And the future of medical innovation is just beginning.

Tilray Brands takes the @Nasdaq tower to mark a pivotal moment for patients, science, and the evolution of global healthcare.

Tilray Medical is ready with global experience and leadership in pharmaceutical-grade medical cannabis cultivation, rigorous quality standards, and a global platform serving hundreds of thousands of patients across more than 20 countries.

This is more than a policy shift. It’s a step toward unlocking research, expanding access, and advancing safe, consistent, high-quality medical solutions.

We’re prepared to lead responsibly. We’re built to scale globally. And we’re focused on what matters most — patients.

#TilrayMedical #MedicalInnovation #Healthcare #Nasdaq #Rescheduling #FutureOfMedicine $TLRY

[Tilray Brands @tilray]

.@manitobaharvest has launched its new Superfood Smoothie Boosters, now available exclusively at Sprouts Farmers Market locations nationwide.

The new functional blends are designed to add a nutrient‑rich boost to everyday smoothies, expanding Manitoba Harvest’s hemp‑based food portfolio and reinforcing its long‑standing focus on plant‑based wellness.

Learn more about the brand's latest launch https://t.co/OrQyRmoCD2 $TLRY

[Tilray Brands @tilray]

Tilray CEO @IrwinDSimon joined @Forbes Newsroom to share his reaction to the US federal rescheduling of cannabis from Schedule I to Schedule III and what it means for the future of the industry.

🎙️ Watch the full interview. https://t.co/sqvfZ0EaQV

$TLRY #Cannabis #Tilray #Rescheduling

[Irwin D. Simon @IrwinDSimon]

Today is a historic moment for the United States.

With President Donald Trump officially rescheduling cannabis, federal policy is taking a meaningful step forward—aligning more closely with science, patient needs, and the reality millions of Americans live every day.

At the heart of this decision are patients.

Cancer patients seeking relief from chemotherapy. Seniors managing chronic pain. Veterans navigating PTSD. For decades, they have looked to medical cannabis as part of their care, and today marks real progress in expanding access and advancing the system that supports them.

This is a major step forward for medical cannabis.

Rescheduling unlocks the potential for accelerated clinical research, greater consistency and quality, and broader access to safe, regulated treatments, helping further establish cannabis as a credible therapeutic option within modern healthcare.

At $TLRY, we’ve built our global platform for this moment.

We operate at pharmaceutical-grade standards across more than 20 countries, serving hundreds of thousands of patients with high-quality medical cannabis products. Our experience in highly regulated markets positions us to help lead responsibly as the U.S. enters this next phase.

What’s most exciting is what comes next - deepening the integration of medical cannabis into healthcare, advancing research, and ensuring patients have access to safe, standardized treatments.

This is a defining milestone and a powerful step forward for patients and the future of healthcare.

[Tilray Brands @tilray]

Tilray Brands Positioned for U.S. Expansion Amid Historic Cannabis Rescheduling

Learn more https://t.co/BlQKD56kJ8 $TLRY